Poolbeg Pharma PLC
POLB.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£2,178 | -£3,532 | -£2 | -£2,120 |
| Dep. & Amort. | £26 | £101 | £0 | £13 |
| Deferred Tax | £0 | £0 | £0 | -£169 |
| Stock-Based Comp. | £0 | £356 | £0 | £50 |
| Change in WC | -£489 | £157 | -£0 | £260 |
| Other Non-Cash | £295 | £534 | -£0 | -£132 |
| Operating Cash Flow | -£2,346 | -£2,384 | -£2 | -£1,836 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£4 | £0 | £0 | £62 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £147 | £0 | £87 |
| Investing Cash Flow | -£4 | £147 | £0 | £149 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £4,487 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | £0 | £0 | £0 |
| Financing Cash Flow | £4,487 | £0 | £0 | £0 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | £2,137 | -£10,061 | -£1 | -£4,022 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £7,824 | £10,061 | £0 | £16,193 |
| End Cash | £9,961 | £0 | -£1 | £12,171 |
| Free Cash Flow | -£2,346 | -£2,384 | -£2 | -£1,949 |